Table 2.
Guideline | Checklist | Sakki et al., 1995 | Merchant et al., 2003 | Al-Zahrani et al., 2005b | Al-Zahrani et al., 2005a | Sanders et al., 2009 | Bawadi et al., 2011 | Samnieng et al., 2013 |
---|---|---|---|---|---|---|---|---|
Study design appropriate to objectives? | Objective common design | |||||||
Prevalence Cross-sectional | ||||||||
Prognosis cohort | ||||||||
Treatment controlled trial | ||||||||
Cause Cohort, case-control, cross-sectional | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Study sample representative? | Source of sample | 0 | ++ | 0 | 0 | 0 | 0 | 0 |
Sampling method | ++ | ++ | ++ | + | 0 | 0 | 0 | |
Sample size | + | + | + | 0 | 0 | + | 0 | |
Entry criteria/exclusion | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Non-respondents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Control group acceptable? | Definition of controls | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Source of controls | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Matching/randomization | 0 | + | + | 0 | + | 0 | 0 | |
Comparable characteristics | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Quality of measurements and outcomes? | Validity | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reproducibility | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Blindness | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Quality control | + | + | 0 | 0 | 0 | 0 | 0 | |
Completeness | Compliance | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Drop outs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Deaths | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Missing data | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Distorting influences? | Extraneous treatments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Contamination | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Changes over time | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Confounding factors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Distortion reduced by analysis | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Summary questions | Bias: | |||||||
Are the results erroneously biased in certain direction? | NO | NO | NO | NO | NO | NO | NO | |
Confounding: | ||||||||
Are there any serious confusing or other distorting influences? | NO | NO | NO | NO | NO | NO | NO | |
Chance: | ||||||||
Is it likely that the results occurred by chance? | NO | NO | NO | NO | NO | NO | NO |